Latest news

Debiopharm Strategic Fund announces FDA clearance of Portfolio Company Immunexpress’ first Test

Immunexpress Closes USD 6 Million Financing Round led by Debiopharm Group™

Debiopharm, Immunexpress and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis